Medtronic launches Complete SE vascular stent

Medtronic has announced that its Complete SE (self-expanding) vascular stent, for use in lower extremity procedures, has received European CE Mark approval and is set for an international launch.

The device is used in the treatment of peripheral artery disease and has proven its efficacy in clinical studies that demonstrated its ability to deliver low clinically-driven target lesion revascularisation rates.

It is approved by the US Food and Drug Administration only for use in the iliac arteries, with the regulator currently reviewing whether or not to expand its indication to include lower extremity applications.

Professor Dierk Scheinert, chairman of the centre for vascular medicine at Part Hospital in Leipzig, said: "The Complete SE stent not only delivers compelling clinical results, but its unique features and delivery system offer an ease-of-use unparalleled with other devices designed to treat lower-extremity lesions."

Last week, the company commenced a new clinical trial using the Reveal Insertable Cardiac Monitor that aims to improve detection of atrial fibrillation among high-risk patients.